/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Novel drug therapies in hypertension: new kids on the block
Event: ESC Congress 2024
Topic: Treatment
Session type: Symposium
A new era in the management of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and cardiovascular complications
Event: ESC Congress 2024
Topic: Chronic Kidney Disease
Session type: Satellite Symposium
New Drugs Made Easy: all you need to know about…
Event: ESC Congress 2024
Topic: Pharmacology and Pharmacotherapy
Session type: Special Session
Clinical trial updates on the GLP-1 receptor agonist, semaglutide
Event: ESC Congress 2024
Topic: European Society of Cardiology
Session type: Late-Breaking Science
Late breaking clinical trials: further analyses and baseline characteristics
Event: Heart Failure 2024
Topic: Heart Failure Association (HFA)
Session type: Late-Breaking Science
Heart Failure Made Easy
Event: ESC Congress 2023
Topic: Chronic Heart Failure
Session type: Special Session
Iron deficiency and the heart: what the cardiologist should know
Event: ESC Congress 2023
Topic: Anaemia/Iron Deficiency
Session type: Satellite Symposium
HOT LINE 2
Event: ESC Congress 2023
Topic: European Society of Cardiology
Session type: Hot Line
Acute heart failure management by settings of care
Event: Heart Failure 2023
Topic: Treatment
Session type: Symposium
Chronic heart failure 2
Event: Heart Failure 2023
Topic: Chronic Heart Failure
Session type: Clinical Cases
